Is GLP-1 Weight Loss Making Muscle the New Priority?

Because the number on the scale can be moving in exactly the direction you want, while something else is moving in the wrong direction.

That is one of the emerging questions around GLP-1-based weight-loss medicines such as semaglutide and tirzepatide. These medications can produce substantial weight loss, but losing weight is not the same thing as losing only body fat.

Some lean mass can disappear during significant weight loss too.

A 2026 systematic review and meta-analysis of 20 randomised controlled trials involving 15,782 people found that lean mass accounted for roughly 25–39% of weight lost with several incretin-based therapies. The picture becomes more encouraging when resistance training is added: lifestyle programmes that included resistance training had the most favourable proportion of lean-mass loss in the analysis.

That does not mean GLP-1 medicines are "bad for muscle". Nor does it mean every kilogram of lean mass lost represents actual muscle tissue, but it does suggest that the goal of weight loss is becoming more sophisticated.

The question is no longer simply, "How much weight did I lose?" It is increasingly, "What did I lose, and what did I keep?"

“Muscle mass can be significantly preserved by integrating resistance training, adequate protein intake, and body composition monitoring into weight-loss treatment programs.”

Why GLP-1 Muscle Loss Is Getting Attention

GLP-1 receptor agonists and related incretin medicines have changed the weight-loss landscape by helping people eat less, largely through effects on appetite and satiety.

That can be hugely meaningful for people who have struggled with excess weight, but when energy intake falls substantially, the body does not draw exclusively from fat stores. Some fat-free or lean tissue can also be lost.

A 2024 systematic review and network meta-analysis, "Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition," of 22 randomised controlled trials involving 2,258 participants found that GLP-1 receptor agonists reduced body weight and fat mass, but also reduced lean mass by an average of 0.86 kg. The researchers estimated that lean mass represented around 25% of total weight lost.

A newer 2026 meta-analysis, “Effect of GLP-1 receptor agonists at doses for obesity management on muscle health,” looking specifically at GLP-1 receptor agonists at obesity-management doses, similarly found a significant reduction in absolute lean mass, although the proportion of lean mass within total body weight increased because fat mass fell more substantially.

"Lean mass" is not synonymous with "muscle". Lean mass measurements can include skeletal muscle, water, organs and other non-fat tissues. Changes in hydration alone can influence the number.

So headlines suggesting that GLP-1 medicines simply "burn muscle" are too simplistic. The real issue is whether people can lose excess fat while retaining as much useful muscle and physical function as possible.

Why Muscle Matters During Weight Loss

Muscle is not just something you notice in the mirror. It helps you climb stairs, carry shopping, get up from a chair, exercise, maintain physical independence, and respond to the demands of everyday life. It is also metabolically active tissue.

That makes muscle particularly relevant when someone is deliberately losing weight. If the scales are dropping but strength, physical function, and lean tissue are also falling substantially, the result may not be as favourable as the scale alone suggests.

This becomes even more relevant with age. Adults naturally tend to lose muscle and strength as they get older. Rapid or substantial weight loss can add another challenge to maintaining lean tissue.

A 2025 review in the "European Journal of Clinical Investigation" concluded that GLP-1-related weight loss is predominantly fat mass, with a more modest absolute decline in lean body mass and no consistent deterioration in strength or physical function. It nevertheless recommends progressive resistance training, adequate high-quality protein, and periodic monitoring of body composition and performance alongside therapy.

In other words, muscle preservation is not about being afraid of weight loss. It is about making the weight you lose count.

Resistance Training May Be the Missing Piece

If weight loss creates pressure on lean mass, resistance training gives your body a reason to keep it. That could mean traditional gym-based weight training, machines, resistance bands, or appropriately progressed bodyweight exercises.

The important part is progressive resistance, giving the muscles a stimulus that tells them they are still needed.

The evidence extends beyond GLP-1 medicines.

A 2025 systematic review and meta-analysis, “Effect of resistance exercise on body composition, muscle strength and cardiometabolic health during dietary weight loss in people living with overweight or obesity,” of 25 randomised controlled trials examined people with overweight or obesity undertaking dietary weight loss with or without resistance exercise. Resistance training did not significantly change total body weight compared with diet alone.

But it did protect against the loss of fat-free mass, increased fat-mass loss and improved muscular strength. The scale may not move more dramatically just because you start lifting weights. In fact, sometimes the opposite can happen.

You may lose fat while retaining more lean tissue, meaning the number on the scale tells only part of the story.

Protein Becomes More Important When Appetite Falls

There is another practical challenge with GLP-1 therapy: eating less can make it harder to consume enough protein. If you used to eat three large meals and now feel satisfied after much smaller portions, your total protein intake may fall without you deliberately changing your diet.

That matters because protein provides the amino acids needed for muscle protein synthesis and helps support the body's response to resistance training.

A 2025 international working-group review on optimising GLP-1 therapies recommends protein intakes above 1.2 g/kg/day in appropriate adults, distributed across meals, alongside aerobic activity and structured resistance training to help preserve lean mass.

That is a clinical recommendation, not a universal prescription. Individual protein needs vary with body size, age, activity, dietary pattern, and health status. People with certain medical conditions may require different advice.

The broader principle is simpler: When you're eating less, the nutritional quality of what you do eat matters more.

Protein-rich foods should have a seat at the table rather than becoming an afterthought.

What Should You Actually Do?

If you are using a GLP-1 medicine, or considering one with your healthcare professional, the fundamentals are surprisingly familiar.

1. Prioritise resistance training. Aim to train major muscle groups regularly and progressively. If you're new to resistance exercise, start at an appropriate level rather than trying to match someone else's programme.

2. Make protein count. Include protein-rich foods across the day rather than trying to consume most of your protein in one enormous meal.

3. Don't let reduced appetite become under-nutrition. Eating less does not automatically mean eating well. Nutrient density becomes increasingly important when overall food intake falls.

4. Track more than body weight. Strength, waist measurements, performance, how you move and, where appropriate, professionally assessed body composition can provide a more useful picture than the scales alone.

5. Keep the bigger picture in view. Sleep, hydration, aerobic activity and overall dietary quality still matter. GLP-1 medication is not a replacement for the habits that support physical function.

A recent international consensus statement similarly emphasises adequate protein, dietary quality and progressive resistance exercise as practical strategies for preserving fat-free mass and physical function during incretin-based therapy.

For people trying to keep nutrition simple while maintaining an active routine, OneFit® is designed as a convenient all-in-one option, providing 25g of protein and 5g of creatine monohydrate alongside electrolytes, L-carnitine, probiotics and methylated B vitamins. It can sit alongside a balanced diet.

When you're trying to stay consistent with protein and exercise-supporting nutrition, convenience can make the routine easier to maintain. The fundamentals still do the heavy lifting: resistance training, sufficient protein, a nutrient-dense diet, recovery, and consistency.